Lessons from the major studies in COPD: problems and pitfalls in translating research evidence into practice

被引:11
作者
Halpin, David M. G. [1 ]
机构
[1] Royal Devon & Exeter Hosp, Exeter EX2 5DW, Devon, England
来源
PRIMARY CARE RESPIRATORY JOURNAL | 2010年 / 19卷 / 02期
关键词
COPD; trials; studies; research; design; methodology; critical analysis; interventions; outcomes; data; OBSTRUCTIVE PULMONARY-DISEASE; FLUTICASONE PROPIONATE/SALMETEROL 250/50; 50; MU-G; SALMETEROL/FLUTICASONE PROPIONATE; COST-EFFECTIVENESS; THERAPEUTIC TRIALS; RANDOMIZED-TRIALS; HEALTH-CARE; EXACERBATIONS; EFFICACY;
D O I
10.4104/pcrj.2010.00015
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Translating the growing evidence base on COPD management into practice can be challenging and understanding the strengths and weakness of published studies is crucial. Studies should conform to the standards of CONSORT statement; they should be sufficiently powered, participants should be randomised, there should be assignment concealment, and the outcome measures and analyses should be decided in advance. The interpretation of the results may be affected by age and severity inclusion criteria for the study and the exclusion of patients with co-morbid illnesses. Whether previous medication is continued or stopped can affect the interpretation of the results. Secondary analyses in sub-groups should be viewed with caution unless pre-specified and accommodated in the trial design and power calculations. Real world observational studies may be confounded by non-randomisation of participants but can sometimes yield valuable insights. The way in which the results are presented can influence their interpretation and their magnitude with respect to minimal important differences as well as statistical significance is important. Research studies help formulate management algorithms but often the questions they address are too specific to allow evidence-based sequencing of therapies. (c) 2010 Primary Care Respiratory Society UK. All rights reserved. DMG Halpin. Prim Care Resp J 2010; 19(2): 170-179 doi:10.4104/pcrj.2010.00015
引用
收藏
页码:170 / 179
页数:10
相关论文
共 62 条
[1]   The revised CONSORT statement for reporting randomized trials: Explanation and elaboration [J].
Altman, DG ;
Schulz, KF ;
Moher, D ;
Egger, M ;
Davidoff, F ;
Elbourne, D ;
Gotzsche, PC ;
Lang, T .
ANNALS OF INTERNAL MEDICINE, 2001, 134 (08) :663-694
[2]  
[Anonymous], Public Health, DOI DOI 10.1016/S0033-3506(02)00027-6
[3]   Effect of Fluticasone Propionate/Salmeterol (250/50) on COPD Exacerbations and Impact on Patient Outcomes [J].
Anzueto, Antonio ;
Ferguson, Gary T. ;
Feldman, Greg ;
Chinsky, Kenneth ;
Seibert, Allan ;
Emmett, Amanda ;
Knobil, Katharine ;
O'Dell, Dianne ;
Kalberg, Christopher ;
Crater, Glenn .
COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2009, 6 (05) :320-329
[4]   A comparison of observational studies and randomized, controlled trials. [J].
Benson, K ;
Hartz, AJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (25) :1878-1886
[5]   Is treatment with ICS and LABA cost-effective for COPD? Multinational economic analysis of the TORCH study [J].
Briggs, A. H. ;
Glick, H. A. ;
Lozano-Ortega, G. ;
Spencer, M. ;
Calverley, P. M. A. ;
Jones, P. W. ;
Vestbo, J. .
EUROPEAN RESPIRATORY JOURNAL, 2010, 35 (03) :532-539
[6]  
Calverley Peter M A, 2005, COPD, V2, P143
[7]   Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease [J].
Calverley, Peter M. A. ;
Anderson, Julie A. ;
Celli, Bartolome ;
Ferguson, Gary T. ;
Jenkins, Christine ;
Jones, Paul W. ;
Yates, Julie C. ;
Vestbo, Jorgen ;
Calverley, P. M. A. ;
Anderson, J. A. ;
Celli, B. ;
Ferguson, G. T. ;
Jenkins, C. ;
Jones, P. W. ;
Knobil, K. ;
Yates, J. C. ;
Vestbo, J. ;
Cherniack, R. ;
Similowski, T. ;
Cleland, J. ;
Whitehead, A. ;
Wise, R. ;
McGarvey, L. ;
John, M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (08) :775-789
[8]   Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials [J].
Calverley, Peter M. A. ;
Rabe, Klaus F. ;
Goehring, Udo-Michael ;
Kristiansen, Soren ;
Fabbri, Leonardo M. ;
Martinez, Fernando J. .
LANCET, 2009, 374 (9691) :685-694
[9]   Maintenance therapy with budesonide and formoterol in chronic obstructive pulmonary disease [J].
Calverley, PM ;
Boonsawat, W ;
Cseke, Z ;
Zhong, N ;
Peterson, S ;
Olsson, H .
EUROPEAN RESPIRATORY JOURNAL, 2003, 22 (06) :912-919
[10]   Withdrawal from treatment as an outcome in the ISOLDE study of COPD [J].
Calverley, PMA ;
Spencer, S ;
Willits, L ;
Burge, PS ;
Jones, PW .
CHEST, 2003, 124 (04) :1350-1356